---
title: "Chengdu huasun technology group Inc., LTD. (000790.SZ)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/000790.SZ.md"
symbol: "000790.SZ"
name: "Chengdu huasun technology group Inc., LTD."
industry: "Pharmaceuticals"
---

# Chengdu huasun technology group Inc., LTD. (000790.SZ)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | CN Market |
| Website | [www.huasungrp.com](https://www.huasungrp.com) |

## Company Profile

Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs.

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-03-02T04:30:10.000Z

**Overall: D (0.73)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 217 / 222 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -33.77% |  |
| Net Profit YoY | -995.41% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.75 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2.57B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 660.67M |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -11.16% | D |
| Profit Margin | -16.74% | D |
| Gross Margin | 39.69% | B |

#### Growth Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -33.77% | E |
| Net Profit YoY | -995.41% | E |
| Total Assets YoY | -13.18% | E |
| Net Assets YoY | -13.26% | E |

#### Cash Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -597.28% | E |
| OCF YoY | -33.77% | E |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.33 | D |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 48.98% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Chengdu huasun technology group Inc., LTD.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-11.16%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-16.74%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "39.69%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "E",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-33.77%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-995.41%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-13.18%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-13.26%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "E",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-597.28%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-33.77%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.33",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "48.98%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Xingqi Pharmaceutical (SZ.300573) | A | A | A | B | B | A |
| 02 | Hengrui Pharma (SH.600276) | A | B | C | A | B | B |
| 03 | Yunnan Baiyao (SZ.000538) | B | C | B | B | C | B |
| 04 | Salubris (SZ.002294) | B | B | C | A | B | B |
| 05 | Haisco (SZ.002653) | B | C | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -22.75 | 184/222 | 195.09 | 190.02 | 182.42 |
| PB | 2.69 | 121/222 | 2.68 | 2.53 | 2.32 |
| PS (TTM) | 3.81 | 91/222 | 3.79 | 3.38 | 2.85 |
| Dividend Yield | 0.00% | - | 0.27% | 0.26% | 0.25% |

## References

- [Company Overview](https://longbridge.com/en/quote/000790.SZ/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/000790.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/000790.SZ/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.